Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
复制标题
DOI：
10.1377/hlthaff.2015.1661
复制
发表时间：
2016-07-01
期刊：
影响因子：
9.7
通讯作者：
Bradford, W. David
中科院分区：
文献类型：
--
作者：
Bradford, Ashley C.;Bradford, W. David
医用大麻合法化一直是过去二十年来国家政策变化中最具争议的领域之一。然而，人们对医用大麻是否在临床上得到显着使用却知之甚少。使用 2010 年至 2013 年 Medicare D 部分参与者填写的所有处方的数据，我们发现，一旦医用大麻法实施，可作为临床替代品的大麻处方药的使用量显着下降。 2013 年，当各州实施医用大麻法时，全国医疗保险计划和参保者支出预计每年减少 1.652 亿美元。医用大麻的供应对医疗保险 D 部分的处方模式和支出有重大影响。
Legalization of medical marijuana has been one of the most controversial areas of state policy change over the past twenty years. However, little is known about whether medical marijuana is being used clinically to any significant degree. Using data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013, we found that the use of prescription drugs for which marijuana could serve as a clinical alternative fell significantly, once a medical marijuana law was implemented. National overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $ 165.2 million per year in 2013. The availability of medical marijuana has a significant effect on prescribing patterns and spending in Medicare Part D.